Stay up-to-date and subscribe to our newsletter
Sign up to stay informed and receive information on healthcare innovation, straight to your inbox
As experts in medical imaging and cardiac safety testing for clinical trials, the hard-working people at BioTel Research provide the ideal combination of personal service, global reach, scientific expertise, and on-time data delivery.
Each day, BioTel Research’s global clinical trials services team meets the demands of Phase I–IV studies for the world’s largest pharmaceutical organizations, specialty pharmaceutical firms, emerging biotechnology companies, contract research organizations (CRO’s) and medical device manufacturers.
As the research division of BioTelemetry, Inc. (Nasdaq: BEAT), we offer wide-reaching and financially stable global support for cardiovascular monitoring in all therapeutic areas and advanced imaging analyses in oncology, cardiology, neurology and metabolic, musculoskeletal and medical device studies.
Our research team comprises key opinion leaders, board-certified radiologists and cardiologists, sub-specialty scientists and skilled technicians. These experts aggregate, evaluate and share high- quality data through a state-of-the-art global infrastructure.
BioTel Research is one of the industry’s leading providers of centralized cardiovascular monitoring. Part of the world’s largest cardiac data infrastructure, we provide all major cardiovascular testing modalities, using state-of-the-art technology to transfer data efficiently and accurately to our secure central data center located near Washington, DC, USA.
In addition to cardiovascular monitoring, BioTel Research offers full-service imaging capabilities for clinical trials. Supporting all major areas of drug and device research imaging, we offer a complete suite of services, using an advanced cloud-based platform that is Part 11 FDA-compliant and always accessible. Our team includes board-certified radiologists, sub-specialty experts, thought leaders, and highly trained technicians who are dedicated to help design and implement the optimal protocol to acquire, evaluate, and transfer accurate, high-quality data through an efficient, cost-effective, and state-of-the-art global infrastructure.
© 2023 BioTelemetry, a Philips Company. All rights reserved